Publications spécialisées

2026

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Tachet J, Meyer SC, Grandoni F, Haefliger E, Nagy-Hulliger M, Halter JP, Passweg JR, Haefliger D, Bardinet C, Decosterd LA, Guidi M, Girardin FR

Clin Pharmacol Ther. 2026 Sep;120(3):753-761

Effects of antidepressant treatment on fetal development and obstetric complications: a retrospective ultrasound study.

Riediker A, Ochsenbein-Kölble N, Simões-Wüst AP, Winterfeld U, Seifritz E, Paulzen M, Schoretsanitis G

J Psychiatr Res. 2026 Jul 22;201:629-634

Selected highlights from the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs.

Scarsi KK, Marzolini C, Marra F, Tseng AL

Top Antivir Med. 2026 Jul 16;34(3):545-553

Optimizing imatinib sampling strategies through a population approach: a crucial step to model-informed precision dosing validation for point-of-care therapeutic drug monitoring.

Pétermann YJ, Chen J, Alberi L, Alexandra S, Veuve F, Choong E, Thoma Y, Rigamonti R, Carvalho BDR, Carrara S, Girardin FR, Buclin T, Csajka C, Guidi M

BMC Pharmacol Toxicol. 2026 Jul 7

Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokinetics.

Briki M, Thoueille P, Joerger M, Chatelut E, Sterle M, Schmitt A, Wagner AD, Buclin T, Carrara S, Guidi M

Cancer Chemother Pharmacol. 2026 Jun 12;96(1)

Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort.

Gerbier E, Abolhassani N, Dupuis M, Oppliger B, Kandhasamy S, Favre G, Maisonneuve E, Winterfeld U, Legardeur H, Ceulemans M, Baud D, Spoendlin J, Panchaud A

BMC Gastroenterol. 2026 Jun 11

Identification, reliability, and validity of drug-drug interaction checkers in chronic diseases: A systematic review.

Gibson BN, Chodapuneedi S, Koh HY, Gupta S, Gasevic D, Wang AY, Marzolini C, Khoo S, Romero L, Dalli L, Janetzki J, Koh HJW, Talic S

Br J Pharmacol. 2026 Jun 8

Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM Study.

Ravix A, Thoma Y, Cathignol A, Thoueille P, Marzolini C, Giannoni E, Buclin T, Csajka C, Dao K, Guidi M

Clin Pharmacokinet. 2026 Jun;65(6):915-927

Expanding hepatocellular carcinoma surveillance strategies in high-risk patients in Switzerland: a cost-effectiveness analysis.

Goossens N, Garay OU, Wolf C, Ambüehl LE, Kugler V, Girardin FR

Swiss Med Wkly. 2026 May 28;156:4469

Brexpiprazole mitigates hyperprolactinaemia induced by paliperidone in a patient with a history of skin reaction to aripiprazole: case report introducing a new therapeutic approach.

Humbert-Claude M, Barbé T, Ionescu MC, Khasian M, Khachouf OT, Blanc AL, Lemoullec-Tourtier D, Widmer N

BJPsych Open. 2026 May 18;12(3):e137

Current perspectives and emerging directions in research and practice: highlights from the 15th Annual International Workshop on Aging and HIV.

Byun JY, Jones R, Iriarte E, Xavier Hall CD, Krause KD, Wang CX, Pahwa S, Lam JO, Falutz J, Masters MC, Corley M, Marzolini C, Greene M, Vera J, Siegler EL, Margolick JB, Ellis RJ, Letendre S, Moore DJ

J Gerontol A Biol Sci Med Sci. 2026 May 7;81(6)

Characterization of isavuconazole pharmacokinetics and pharmacodynamics in a real-life cohort.

Guidi M, Couchepin J, Reinhold I, Kronig I, Neofytos D, Schreiber PW, André P, Buclin T, Lamoth F

JAC Antimicrob Resist. 2026 Jun;8(3):dlag071

Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug-drug interactions (ACCURATE-DDI).

Ready EA, Patterson C, Gibbons S, Yoong D, Marzolini C, Walker LE, Tseng A

AIDS. 2026 Apr 13

Model-Based Strategy for 6-Mercaptopurine Treatment in Acute Lymphoblastic Leukemia Maintenance Phase: Prediction of 6-TGN and 6-MMP Concentrations to Optimize Treatment.

Ravix A, Maillat A, Choong E, Csajka C, Guidi M, Ceppi F

Pediatr Blood Cancer. 2026 Apr;73(4):e70167

Population pharmacokinetics of encorafenib and binimetinib in real-world patients with BRAF(V600E/K)-mutant metastatic melanoma.

Pétermann YJ, Puszkiel A, Khani A, Kramkimel N, Funck-Brentano E, Oules B, Bouchereau S, Vidal M, Decleves X, Csajka C, Blanchet B, Guidi M

Cancer Chemother Pharmacol. 2026 Mar 17;96(1)

[N-of-1 trials forstatin intolerance : feasibility in clinical practice].

Diezi L, Buclin T, Nanchen D, Girardin F, Brutus L

Rev Med Suisse. 2026 Mar 4;22(952):439-443

Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control.

Thoueille P, Danion A, Hostrup M, Petrou M, Deventer K, Buclin T, Girardin FR, Mazzoni I, Rabin O, Guidi M

CPT Pharmacometrics Syst Pharmacol. 2026 Feb;15(2):e70187

Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current Challenges.

Carrara S, Widmer N, Rodino F, Du L, Briki M, Decosterd LA, Marzolini C, Buclin T, Thoma Y, Guidi M

Ther Drug Monit. 2026 Feb 1;48(1):42-53

Polypharmacy in HIV: Rethinking what counts and why it matters.

Sukumaran L, Winston A, Marzolini C, Khoo S, Boffito M, Naous N, Sabin CA

HIV Med. 2026 Feb;27(2):186-199

Sorafenib plus selective internal radiotherapy with (90)Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial.

Berthod G, Cisarovsky C, Petrova T, Decosterd LA, Choong E, Celestini D, Cuendet MA, Boughdad S, Prior JO, Meuwly JY, Figg WD, Michielin O, Leyvraz S

Br J Cancer. 2026 Feb;134(4):589-597

Population Pharmacokinetics of Propofol in Critically Ill Patients with and Without Extracorporeal Membrane Oxygenation.

Bertin S, Haefliger D, Mercier T, Decosterd LA, Giraud R, Assouline B, Schneider A, Buclin T, Guidi M, Livio F

Clin Pharmacokinet. 2026 Feb;65(2):229-240

Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO.

Bertin S, Guidi M, Haefliger D, Thoueille P, Bardinet C, Decosterd LA, Perez MH, Giraud R, Assouline B, Schneider A, Buclin T, Livio F

Clin Pharmacokinet. 2026 Feb;65(2):241-255

[Pharmacotherapy of neuromuscular diseases : what's new in 2025].

Ghika N, Accolla E, Girardin F, Theaudin M

Rev Med Suisse. 2026 Jan 14;22(945):66-70

Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report.

Klingmüller A, Zuber S, Hoffmann AM, Köhler N, Suárez I, Preßel T, Niemann S, Dreyer V, Decosterd LA, Choong E, Schütz B, Friesen I, Rybniker J

JAC Antimicrob Resist. 2026 Feb;8(1):dlaf251

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025.

Ambrosioni J, Levi LI, Alagaratnam J, Sempere A, Mastrangelo A, Paioni P, Mussini C, Marzolini C, Nielsen SD, Béguelin C, Welch S, Koval A, Mendao L, Bamford A, Calmy A, Guaraldi G, Oprea C, Martínez E, Rockstroh JK, EACS Governing Board

HIV Med. 2026 Jan;27(1):18-32

CFTR during pregnancy and adverse drug reactions: A pharmacovigilance disproportionality analysis in VigiBase.

Abolhassani N, Dao K, Noseda R, Bedussi F, Ceschi A, Panchaud A, Winterfeld U

J Cyst Fibros. 2026 Jan;25(1):21-27

Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?

Wordi D, Nguyen HT, Livio F, Boffito M, Manuel O, Marzolini C

Expert Opin Drug Metab Toxicol. 2026 Jan-Feb;22(2):169-179

The Feasibility and Quality of the European Prescribing Exam: An International Multicenter Pilot Study Among 3109 Medical Students From 16 Medical Schools.

Donker EM, Piët JD, Brinkman DJ, Richir MC, Papaioannidou P, Likic R, Sanz EJ, Christiaens T, Costa JN, De Ponti F, Böttiger Y, Kramers C, van Agtmael MA, Tichelaar J, Erasmus+ consortium EuroPE+ and the EACPT Education Working Group

Clin Pharmacol Ther. 2026 Jan;119(1):190-197

Screening for antibiotic residues among adults with respiratory infections in primary care in Switzerland: evaluating over-the-counter use and environmental exposure.

Wäfler N, Knüsli J, Lhopitallier L, Senn N, Marzolini C, Boillat-Blanco N

Clin Microbiol Infect. 2026 Jan;32(1):196-198

Dual-Biosensor for Five Drugs Detection in Precision Oncology.

Rodino F, Briki M, Buclin T, Guidi M, Carrara S

Bionanoscience. 2026;16(4):258

2025

Levetiracetam-induced rhabdomyolysis: a rare adverse effect in a patient with status epilepticus.

Crausaz L, Baumgartner T, Haefliger D, Rossetti AO

Neurol Sci. 2025 Dec 27;47(1):54

Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?

Ravix A, Di Paolo ER, Dao K, Perez MH, Crisinel PA, Buclin T, André P, Marzolini C, Csajka C, Guidi M

J Antimicrob Chemother. 2025 Dec 2;80(12):3419-3430

Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase.

Abolhassani N, Noseda R, Dao K, Girardin FR, Bedussi F, Ceschi A, Panchaud A, Winterfeld U

Clin Transl Sci. 2025 Dec;18(12):e70429

Weight loss following gastric bypass increases aldosterone reactivity to orthostatic stress in patients with obesity.

Zahnd J, Vakilzadeh N, Schwotzer N, Hendriks-Balk M, Mantziari S, Sauser J, Maillard M, Grouzmann E, Favre L, Wuerzner G

Blood Press. 2025 Dec;34(1):2555452

Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo Experiments.

Bertin S, Haefliger D, Schneider AG, Giraud R, Perez MH, Bechtold X, Di Paolo ER, Rothuizen LE, Buclin T, Livio F

J Clin Med. 2025 Nov 13;14(22)

International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness.

Kuriakose S, Tseng A, Boyd S, Gibbons S, Chiong J, Marra F, Boyle A, Senneker T, George J, Lund C, Belperio P, Crew P, Eschenauer G, Scarsi KK, Khoo SH, Pau A, Marzolini C, LiON-PK collaboration

Clin Infect Dis. 2025 Nov 3

Percutaneous Radiofrequency Ablation After Incomplete Adrenalectomy in a Lateralized Case of Primary Aldosteronism.

Rigon PA, Villard N, Abid KA, Zingg T, Eimer S, Wuerzner G

JCEM Case Rep. 2025 Dec;3(12):luaf251

Communicating medication risks in pregnancy: Towards shared decision making.

Winterfeld U, Hodson K, Berlin M, Marin B, Ceulemans M, Weber-Schoendorfer C, Girardin FR, Baud D, Schaad B, Panchaud A

Front Drug Saf Regul. 2025;5:1712216

Leukocyte count and new-onset diabetes mellitus in people with HIV: A longitudinal study.

Meyer SC, Klein Z, Schoepf IC, Thorball CW, Labarile M, Kootstra NA, Reiss P, Ryom L, Braun DL, Thurnheer MC, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Fellay J, Günthard HF, Kouyos RD, Ledergerber B, Tarr PE, Swiss HIV Cohort Study

HIV Med. 2025 Oct;26(10):1585-1599

Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?

Tachet J, Marzolini C, Decosterd LA, Guidi M, Girardin FR

Expert Rev Clin Pharmacol. 2025 Oct;18(10):1-17

Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study.

Tachet J, Decosterd LA, Guidi M, Girardin FR

JMIR Res Protoc. 2025 Sep 9;14:e70312

A Scoping Review of Human Teratogens and Their Impact on the Developing Brain: A Contribution From the ConcePTION Project.

Bluett-Duncan M, Adams J, Berkovitch M, Berlin M, Cahoon A, Clayton-Smith J, Jackson C, Khanom S, Mølgaard-Nielsen D, Richardson JL, Simms V, Stellfeld M, Winterfeld U, Yates LM, Bromley RL

Birth Defects Res. 2025 Sep;117(9):e2497

Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort Study.

Labarile M, Schoepf IC, Pasin C, Oumelloul MA, Thorball CW, Riebensahm C, Surial B, Wandeler G, Braun DL, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Calmy A, Nemeth J, Bally L, Reiss P, Telenti A, Ledergerber B, Günthard HF, Fellay J, Zamboni N, Kouyos RD, Tarr PE, Swiss HIV Cohort Study

J Infect Dis. 2025 Aug 27

A comparison between venous blood sampling and capillary volumetric absorptive microsampling for antibiotics levels monitoring in individuals with and without periodontal disease.

Lazaridi I, Choong E, Mercier T, Decosterd LA, Giannopoulou C, Zekeridou A

Clin Oral Investig. 2025 Aug 23;29(9):420

Is Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine of Clinical Utility?

Marzolini C

Clin Infect Dis. 2025 Aug 18

Population pharmacokinetics of bictegravir in real-world people with HIV.

Ekobena P, Briki M, Dao K, Marzolini C, Andre P, Buclin T, Cavassini M, Guidi M, Thoueille P, Swiss HIV Cohort Study

J Antimicrob Chemother. 2025 Aug 13

Pragmatic and contextualized methods selection for safety assessment of infant systemic exposure through human milk: the Milk4baby decision tree approach - a contribution from the concePTION project.

Monfort A, Macente J, Van Neste M, Huang MC, Nauwelaerts N, Abza GB, Winterfeld U, Smits A, Allegaert K, Annaert P, Guidi M, Panchaud A

Front Pharmacol. 2025;16:1602018

Rifampicin Exposure in Tuberculosis Patients with Comorbidities in Sub-Saharan Africa: Prioritising Populations for Treatment-A Systematic Review and Meta-analysis.

Said B, Pétermann Y, Howlett P, Guidi M, Thoma Y, Kajogoo VD, Sariko M, Heysell SK, Alffenaar JW, Mpolya E, Mpagama S

Clin Pharmacokinet. 2025 Aug;64(8):1149-1163

Is Nonsustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Really Independent of Drug Levels?

Thoueille P, Marzolini C, Guidi M, Cavassini M, Decosterd LA

Clin Infect Dis. 2025 Aug 1;81(1):e4-e5

Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational study.

Bertin S, Haefliger D, Perez MH, Guidi M, Decosterd LA, Chanez V, Di Paolo ER, Buclin T, Livio F

Front Pediatr. 2025;13:1542417

Is the salivary concentration of lamotrigine and levetiracetam associated with clinical outcome?

Vassallo P, Choong E, Aícua-Rapún I, Stampfli C, André P, Rossetti AO, Buclin T, Decosterd LA, Novy J

Epilepsy Behav. 2025 Jul 21;171:110595

Numerical Verification of Tucuxi, a Promising Bayesian Adaptation Tool for Model-Informed Precision Dosing.

Ravix A, Cathignol AE, Buclin T, Csajka C, Guidi M, Thoma Y

CPT Pharmacometrics Syst Pharmacol. 2025 Jul 17

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole.

Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB

Schizophr Bull. 2025 Jul 14

A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation.

Kervella D, Casanova-Ferrer F, Kotton CN, Donadeu L, Kumar D, Pineda S, Crespo E, Meneghini M, González-Costelo J, García-Romero E, Lladó L, Cachero A, Melilli E, Torres IB, Martínez-Lacalle A, Castañeda Z, Martinez-Gallo M, Len O, Los-Arcos I, Trilla-Herrera E, Miret E, Giral M, Brouard S, Girardin FR, Villard J, Budde K, Lefaucheur C, Loupy A, Moreso F, Bestard O

Kidney Int Rep. 2025 Sep;10(9):3044-3057

Quality of Clinical Information in Pregnancy Pharmacovigilance Data Sources-A Contribution of the ConcePTION Project.

van Rijt-Weetink YRJ, van Gendt J, Egberts TCG, van Hunsel FPAM, Lewis DJ, Yates LM, Winterfeld U, van Puijenbroek EP

Pharmacoepidemiol Drug Saf. 2025 Jul;34(7):e70182

Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study.

Hilfiker A, Schoepf IC, Avery EF, Ledergerber B, Colin-Benoit E, Riebensahm C, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Günthard HF, Kouyos R, Nemeth J, Tarr PE, Swiss HIV Cohort Study

J Acquir Immune Defic Syndr. 2025 Jun 20

Types of Myocardial Infarction in People With HIV in Switzerland.

Kleynhans JN, Cobo NN, Avery EF, Buechel RR, Thorball CW, Schoepf IC, Coscia T, Braun DL, Colin-Benoit E, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Kusejko K, Fellay J, Günthard HF, Ledergerber B, Tarr PE, Swiss HIV Cohort Study

Open Forum Infect Dis. 2025 Jul;12(7):ofaf357

Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.

Groen K, Kuratli R, Enkelmann J, Fernbach S, Wendel-Garcia PD, Staiger WI, Lejeune M, Sauras-Colón E, Roche-Campo F, Filippidis P, Rauch A, Swiss HIV Cohort Study, Trkola A, Günthard HF, Kouyos RD, Brugger SD, Hale BG

J Exp Med. 2025 Jun 2;222(6)

Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis.

Wagner E, Korman N, Solmi M, Mortazavi M, Aminifarsani Z, Dubrovin Leão D, Burrage MK, Siskind D, McMahon L, Howes OD, Correll CU, CAM Expert Group, Hasan A

Br J Psychiatry. 2025 Jun 2:1-9

Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme Disease.

Ravix A, Gotta V, Pfister M, Berger C, Glauser A, Paioni P, Csajka C, Guidi M

J Clin Pharmacol. 2025 Jun;65(6):742-750

Delphi Method Consensus on Statistical Analysis and Reporting Recommendations for Single-Arm Pregnancy Medication Safety Studies Investigating Pregnancy, Birth and Neonatal Health Outcomes: A Contribution from IMI-ConcePTION.

Richardson JL, Moore A, Stellfeld M, Geissbühler Y, Winterfeld U, Favre G, Chambers C, Beck E, Onken M, Dathe K, Ceulemans M, Diav-Citrin O, Shechtman S, Oliver AM, Hodson KK, Shiller DD, Alexe A, van Puijenbroek EP, Lewis DJ, Yates LM

Drug Saf. 2025 Jun;48(6):643-654

[Glucagon-like peptide 1 agonists : the fourth pillar of nephroprotection in type 2 diabetes].

Lamine F, Chtioui H, Zanchi A

Rev Med Suisse. 2025 May 28;21(920):1117-1120

Roux-en-Y gastric bypass in a patient with Wilson's disease and obesity.

Balaphas A, Sempoux C, Samer CF, Chtioui H, Saadi A, Collaborators

J Hepatol. 2025 May;82(5):e222-e223

Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease.

Alagaratnam J, van Bremen K, Behrens GMN, Boccara F, Cinque P, Gisslén M, Guaraldi G, Konopnicki D, Kowalska JD, Mallon PWG, Marzolini C, Mendão L, Miró JM, Negredo E, Reiss P, Ryom L, van der Valk M, Winston A, Nielsen SD, Martínez E

Lancet HIV. 2025 May;12(5):e382-e392

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring.

D'Atri V, Corrado F, Versace F, Saldanha SA, Mercier T, Guidi M, Thoueille P, Blanchon S, Koutsokera A, Vogeser M, Marzolini C, Girardin F, Mitropoulou G, Balmpouzis Z, Rochat I, Sauty A, Decosterd LA, Choong E

Molecules. 2025 Apr 22;30(9)

Risk of adverse obstetrical and neonatal outcomes in women consuming recreational drugs during pregnancy.

Kandhasamy S, Lepigeon K, Baggio S, Céline R, Ceulemans M, Winterfeld U, Jenkinson SP, Francini K, Maisonneuve E, Panchaud A

BMC Pregnancy Childbirth. 2025 Apr 16;25(1):456

Initiating or Resuming Cancer Treatment After Ischemic Stroke and Clinical Outcomes.

Costamagna G, Hottinger AF, Strambo D, Livio F, Navi BB, Michel P

Neurology. 2025 Apr 8;104(7):e213458

Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine.

Pallanza M, Thoueille P, Briki M, Alves Saldanha S, Cavassini M, Marzolini C

Antivir Ther. 2025 Apr;30(2):13596535251335080

Highly sensitive ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method for the multiplex analysis of levosimendan and its metabolites OR-1855 and OR-1896 in human plasma.

Bertin S, Versace F, Mercier T, Murisier A, Sauvain G, Haefliger D, Girardin FR, Perez MH, Giraud R, Schneider A, Buclin T, Decosterd LA, Choong E, Livio F

J Pharm Biomed Anal. 2025 Mar 15;255:116612

Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis.

Haefliger D, Mina L, Guidi M, Marzolini C, Thoueille P, Rothuizen LE, Thoma Y, Decosterd LA, Guery B, Girardin FR, Buclin T

J Antimicrob Chemother. 2025 Mar 3;80(3):840-847

N-of-1 tests in general practice: pharmacological considerations.

Diezi L, Anastasi M, Brutus L, Buclin T

Br J Gen Pract. 2025 Mar;75(752):132-135

Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.

Sablik M, Sannier A, Raynaud M, Goutaudier V, Divard G, Astor BC, Weng P, Smith J, Garro R, Warady BA, Zahr RS, Twombley K, Dharnidharka VR, Dandamudi RS, Fila M, Huang E, Sellier-Leclerc AL, Tönshoff B, Rabant M, Verine J, Del Bello A, Berney T, Boyer O, Catar RA, Danger R, Giral M, Yoo D, Girardin FR, Alsadi A, Gourraud PA, Morelon E, Le Quintrec M, Try M, Villard J, Zhong W, Bestard O, Budde K, Chauveau B, Couzi L, Brouard S, Hogan J, Legendre C, Anglicheau D, Aubert O, Kamar N, Lefaucheur C, Loupy A

N Engl J Med. 2025 Feb 20;392(8):763-776

Population-Based Prevalence of Antibiotic Residuals in Low, Moderate and High Malaria Endemicity Areas in Tanzania.

Lotto T, Gallay J, Zuakulu M, Ternon B, Decosterd LA, Kulinkina AV, Genton B

Antibiotics (Basel). 2025 Feb 13;14(2)

Enhancing perinatal health patient information through ChatGPT - An accuracy study.

de Vries PLM, Baud D, Baggio S, Ceulemans M, Favre G, Gerbier E, Legardeur H, Maisonneuve E, Pena-Reyes C, Pomar L, Winterfeld U, Panchaud A

PEC Innov. 2025 Jun;6:100381

Pénurie de médicaments : « Les actions concrètes restent relativement limitées ».

Buclin T

Rev Med Suisse. 2025 Feb 5;21(904):249-250

Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA-COVID-19 vaccine compared with unexposed infants: a COVI-PREG prospective cohort study.

Favre G, Bromley RL, Bluett-Duncan M, Maisonneuve E, Pomar L, Daire C, Radan AP, Raio L, Surbek D, Blume C, Kalimeris S, Madec Y, Schneider J, Bickle Graz M, Winterfeld U, Panchaud A, Baud D

Clin Microbiol Infect. 2025 Feb;31(2):266-273

Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling.

Gaspar F, Jacost-Descombes C, Gosselin P, Reny JL, Guidi M, Csajka C, Samer C, Daali Y, Terrier J

Clin Pharmacokinet. 2025 Feb;64(2):275-283

Clinical value of saliva therapeutic drug monitoring of newer antiseizure medications.

Choong E, Vassallo P, Aícua-Rapún I, Stampfli C, André P, Rossetti AO, Buclin T, Novy J, Decosterd LA

Seizure. 2025 Feb;125:106-112

Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study.

Cancela Costa A, Grass F, Andres Cano I, Desgranges F, Delabays C, Kritikos A, Glampedakis E, Buclin T, Duran R, Guery B, Pagani J-L, Uldry E, Decosterd LA, Lamoth F

Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0117824

[Teratovigilance. Antiepileptics during pregnancy and paternal use].

Dao K, Diezi L, Haefliger D, Novy J, Girardin FR, Winterfeld U

Rev Med Suisse. 2025 Jan 15;21(900-1):77-80

Acute aseptic meningitis temporally associated with trimethoprim and sulfamethoxazole: Systematic review.

Bernasconi GF, Milani GP, De Felice ELT, Laurence C, Faré PB, Terziroli Beretta-Piccoli B, Bianchetti MG, Lava SAG

Br J Clin Pharmacol. 2025 Jan;91(1):236-243

Population pharmacokinetic modelling of cetirizine concentrations in human breast milk-A contribution from the ConcePTION project.

Melander E, Nielsen EI, Lindqvist A, Hovd M, Gandia P, Panchaud A, Guidi M, Annaert P, Baranczewski P, Spigset O, Nordeng H

Basic Clin Pharmacol Toxicol. 2025 Jan;136(1):e14100

Removal of Meropenem and Piperacillin during Experimental Hemoadsorption with the HA380 Cartridge.

Furukawa T, Lankadeva Y, Baldwin I, Ow PCC, Hood S, Schneider A, Decosterd LA, May CN, Bellomo R

Blood Purif. 2025;54(2):102-110

Removal of Psychotropic Drugs by Hemoadsorption with the HA380 Cartridge.

Furukawa T, Lankadeva YR, Baldwin IC, Ow PCC, Hood S, Eap CB, Schneider A, Decosterd LA, Bellomo R

Blood Purif. 2025;54(12):715-722

Removal of Ticagrelor by Hemoadsorption with the HA380 Cartridge.

Furukawa T, Lankadeva YR, Baldwin IC, Ow PCC, Hood S, Daali Y, Schneider A, Decosterd LA, May CN, Bellomo R

Blood Purif. 2025;54(4-5):226-230

Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavir.

Marzolini C, Gibbons S, Seddon D, Khoo S

Expert Opin Drug Metab Toxicol. 2025 Jan-Feb;21(2):161-172

Importance of Sex-Dependent Differences for Dosing Selection and Optimization of Chemotherapeutic Drugs.

Seydoux C, Briki M, Wagner AD, Choong E, Guidi M, Carrara S, Thoma Y, Livio F, Girardin FR, Marzolini C, Buclin T, Decosterd LA

Chemotherapy. 2025;70(2):92-101

2024

Impact of adolescents' binge drinking on blood chemistry.

Pistritto E, Schera FMF, Vassilopoulou E, Corsello A, Alberti I, Lava SAG, Betti C, Bianchetti MG, Agostoni C, Camozzi P, Milani GP

Eur J Pediatr. 2024 Dec 12;184(1):77

Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.

Sáez-Cirión A, Mamez AC, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P, Decosterd L, Hentzien M, Perdomo-Celis F, Salgado M, Nijhuis M, Mélard A, Gardiennet E, Lorin V, Monceaux V, Chapel A, Gourvès M, Lechartier M, Mouquet H, Wensing A, Martinez-Picado J, Yerly S, Rougemont M, Calmy A

Nat Med. 2024 Dec;30(12):3544-3554

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV.

Thoueille P, Saldanha SA, Schaller F, Choong E, Veuve F, Munting A, Cavassini M, Braun D, Günthard HF, Duran Ramirez JJ, Surial B, Furrer H, Rauch A, Ustero P, Calmy A, Stöckle M, Di Benedetto C, Bernasconi E, Schmid P, Marzolini C, Girardin FR, Buclin T, Decosterd LA, Guidi M

Front Pharmacol. 2024;15:1437400

State of the art of real-life concentration monitoring of rifampicin and its implementation contextualized in resource-limited settings: the Tanzanian case.

Petermann YJ, Said B, Cathignol AE, Sariko ML, Thoma Y, Mpagama SG, Csajka C, Guidi M

JAC Antimicrob Resist. 2024 Dec;6(6):dlae182

Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENTIS).

Onken M, Lohse L, Coulm B, Beghin D, Richardson JL, Bermejo-Sánchez E, Aguilera C, Bosch M, Cassina M, Chouchana L, De Santis M, Duman MK, Gören MZ, Johnson D, Bera APJ, Kaplan YC, Kennedy D, Kwok S, Lacroix I, Lepelley M, Pistelli A, Schaefer C, Te Winkel B, Uysal N, Winterfeld U, Yakuwa N, Diav-Citrin O, Vial T, Dathe K

Acta Psychiatr Scand. 2024 Nov;150(5):372-384

A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION project.

Monfort A, Cardoso E, Eap CB, Ansermot N, Crettol S, Fischer Fumeaux CJ, Graz MB, Harari MM, Weisskopf E, Gandia P, Allegaert K, Annaert P, Nordeng H, Hascoët JM, Claris O, Epiney M, Ferreira E, Leclair G, Csajka C, Panchaud A, Guidi M, collaborators of the SSRI Breast Milk study

Br J Clin Pharmacol. 2024 Nov;90(11):2849-2860

Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report.

Haefliger D, Chehade H, Livio F, Rodrigues-Veiga V, Diezi L, Marzolini C

Semin Dial. 2024 Nov-Oct;37(6):461-465

Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and Implementation.

Thoma Y, Cathignol AE, Pétermann YJ, Sariko ML, Said B, Csajka C, Guidi M, Mpagama SG

JMIR Res Protoc. 2024 Oct 21;13:e58720

Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.

Marinosci A, Sculier D, Wandeler G, Yerly S, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Decosterd L, Günthard HF, Schmid P, Limacher A, Branca M, Calmy A, Swiss HIV Cohort Study

Open Forum Infect Dis. 2024 Nov;11(11):ofae618

Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV.

Damas J, Munting A, Fellay J, Haerry D, Marzolini C, Tarr PE, Steffen A, Braun DL, Stoeckle M, Bernasconi E, Nawej Tshikung O, Fux CA, Darling KEA, Béguelin C, Wandeler G, Cavassini M, Surial B, Swiss HIV Cohort Study (SHCS)

Clin Infect Dis. 2024 Oct 15;79(4):990-998

Ideal Time to Conduct a Pharmacokinetic Investigation After Delivery to Fully Capture the Effect of Pregnancy on Drug Exposure.

Berton M, Stader F, Bettonte S, Battegay M, Marzolini C

Open Forum Infect Dis. 2024 Oct;11(10):ofae585

Epstein-Barr virus as promoter of Lemierre syndrome: systematic literature review.

Delcò AA, Montorfani SMMA, Gualtieri R, Lava SAG, Milani GP, Bianchetti MG, Bronz G, Faré PB, Kottanattu L

Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5497-5502

Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.

Dao K, Buettcher M, Golhen K, Kost J, Schittny A, Duthaler U, Atkinson A, Haefliger D, Guidi M, Bardinet C, Chtioui H, Boulekbache A, Buclin T, Huwyler J, Pfister M, Rothuizen LE

J Clin Pharmacol. 2024 Oct;64(10):1295-1303

Transient secondary pseudo-hypoaldosteronism in infants with urinary tract infections: systematic literature review.

Betti C, Lavagno C, Bianchetti MG, Kottanattu L, Lava SAG, Schera F, Lacalamita MC, Milani GP

Eur J Pediatr. 2024 Oct;183(10):4205-4214

Drug-Related Pyroglutamic Acidosis: Systematic Literature Review.

Scafetta T, Kovacs O, Milani GP, Bronz G, Lava SAG, Betti C, Vanoni F, Bianchetti MG, Faré PB, Camozzi P

J Clin Med. 2024 Sep 27;13(19)

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.

Abela IA, Chammartin F, Amstutz A, Surial B, Ballif M, Marzolini C, Aebi-Popp K, Notter J, Segeral O, Stoeckle M, Cavassini M, Bernasconi E, Günthard HF, Kouyos RD, Pasin C, Swiss HIV Cohort Study

Open Forum Infect Dis. 2024 Sep;11(9):ofae502

Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.

Golhen K, Buettcher M, Huwyler J, van den Anker J, Gotta V, Dao K, Rothuizen LE, Kobylinski K, Pfister M

Pharmaceutics. 2024 Sep 7;16(9)

Prevalence of actionable pharmacogenetic variants and high-risk drug prescriptions: A Swiss hospital-based cohort study.

Hodel F, De Min MB, Thorball CW, Redin C, Vollenweider P, Girardin F, Fellay J

Clin Transl Sci. 2024 Sep;17(9):e70009

Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data.

Winterfeld U

Drug Saf. 2024 Sep;47(9):841-842

Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).

Goutaudier V, Danger R, Catar RA, Racapé M, Philippe A, Elias M, Raynaud M, Aubert O, Bouton D, Girardin F, Vicaut É, Yaiche S, Demotes J, Heidecke H, Taupin JL, Randoux-Lebrun C, Zaidan M, Papuchon E, Le Mai H, Nguyen TV, Moreso F, Berney T, Villard J, Legendre C, Dragun D, Papalois V, Potena L, Giral M, Gourraud PA, Brouard S, Crespo E, Halleck F, Budde K, Bestard O, Loupy A, Lefaucheur C, EU-TRAIN Consortium

Kidney Int. 2024 Aug 27

Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling Study.

Bettonte S, Berton M, Stader F, Battegay M, Marzolini C

Clin Infect Dis. 2024 Aug 16;79(2):477-486

Prevalence and predictors of residual antibiotics in children's blood in community settings in Tanzania.

Lotto T, Renggli S, Kaale E, Masanja H, Ternon B, Décosterd LA, D'Acremont V, Genton B, Kulinkina AV

Clin Microbiol Infect. 2024 Aug;30(8):1042-1048

Exposures to non-therapeutic chemicals before, during and after pregnancy: data from the Swiss Teratogen Information Service (STIS).

Srikantha P, Winterfeld U, Girardin F, Panchaud A, Ochsenbein-Kölble N, Simões-Wüst AP

Swiss Med Wkly. 2024 Jul 16;154:3751

Antifungal drug penetration in soft tissue abscesses: a comparative analysis.

Cancela Costa A, Kritikos A, Glampedakis E, Da Silva Pereira Clara J, Schaller F, Mercier T, Strasser R, Balmpouzis Z, Koutsokera A, Manuel O, Buclin T, Decosterd LA, Lamoth F

J Antimicrob Chemother. 2024 Jul 1;79(7):1668-1672

Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations.

Bongiovanni M, Thoueille P, Barda B, Mercier T, Marzolini C, Ramponi N, Choong E, Cantù M, Decosterd LA, Bernasconi E

Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1503-1504

Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection.

Maurer J, Eugster PJ, Collins K, Vocat C, Oke J, Nicholson B, Rakauskas A, Grouzmann E, Valerio M

Eur Urol Open Sci. 2024 Aug;66:12-15

Quantification of endogenous Angiotensin 1-10, 1-9, 1-8, 1-7, and 1-5 in human plasma using micro-UHPLC-MS/MS: Outlining the importance of the pre-analytics for reliable results.

Maurer J, de Groot A, Martin L, Grouzmann E, Wuerzner G, Eugster PJ

J Pharm Biomed Anal. 2024 Jun 15;243:116101

Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study.

Ravix A, Bandiera C, Cardoso E, Lata-Pedreira A, Chtioui H, Decosterd LA, Wagner AD, Schneider MP, Csajka C, Guidi M

Cancers (Basel). 2024 Jun 11;16(12)

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.

Audran R, Chtioui H, Thierry AC, Mayor CE, Vallotton L, Dao K, Rothuizen LE, Maghraoui A, Pennella EJ, Brunner-Ferber F, Buclin T, Spertini F

Sci Rep. 2024 Jun 4;14(1):12872

Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.

Clin Pharmacol Ther. 2024 Jun;115(6):1450-1459

Population Pharmacokinetics in Oncology and Its Clinical Applications.

Widmer N, Guidi M, Buclin T

Pharmaceutics. 2024 May 25;16(6)

Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.

Cannilla H, Messe M, Girardin F, Borruat FX, Bally JF

Tremor Other Hyperkinet Mov (N Y). 2024;14:23

DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy.

Pham T, Ghafoor M, Grañana-Castillo S, Marzolini C, Gibbons S, Khoo S, Chiong J, Wang D, Siccardi M

NPJ Syst Biol Appl. 2024 May 6;10(1):48

Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs.

Bettonte S, Berton M, Battegay M, Stader F, Marzolini C

CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):781-794

Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).

Couchepin J, Reinhold I, Kronig I, Guidi M, Buclin T, Schreiber PW, Neofytos D, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS)

Open Forum Infect Dis. 2024 May;11(5):ofae223

Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.

Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad RH, Berlin M, Hazan A, Richardson JL, Eleftheriou G, Rousson V, Diezi L, Haefliger D, Simões-Wüst AP, Addor MC, Baud D, Lamine F, Panchaud A, Buclin T, Girardin FR, Winterfeld U

BMJ Open. 2024 Apr 24;14(4):e083550

Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.

Marinosci A, Sculier D, Wandeler G, Yerly S, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Buzzi M, Metzner KJ, Decosterd L, Günthard HF, Schmid P, Limacher A, Branca M, Calmy A

Swiss Med Wkly. 2024 Apr 15;154:3762

Hypertension in a Patient With Polycystic Kidney Disease Complicated by Concomitant Pheochromocytoma.

Ameti A, Kopp PA, Pitteloud N, Wuerzner G, Grouzmann E, Matter M, Lamine F, Phan O

AACE Clin Case Rep. 2024 Jul-Aug;10(4):136-139

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.

Briki M, Murisier A, Guidi M, Seydoux C, Buclin T, Marzolini C, Girardin FR, Thoma Y, Carrara S, Choong E, Decosterd LA

J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Apr 1;1236:124039

Population pharmacokinetic analysis of doravirine in real-world people with HIV.

Thoueille P, Delarive L, Cavassini M, Buclin T, Decosterd LA, Marzolini C, Girardin FR, Guidi M, Swiss HIV Cohort Study

Br J Clin Pharmacol. 2024 Apr;90(4):1058-1065

Acute ischaemic stroke in active cancer versus non-cancer patients: stroke characteristics, mechanisms and clinical outcomes.

Costamagna G, Hottinger AF, Milionis H, Salerno A, Strambo D, Livio F, Navi BB, Michel P

Eur J Neurol. 2024 Apr;31(4):e16200

Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling Study.

Bettonte S, Berton M, Stader F, Battegay M, Marzolini C

Open Forum Infect Dis. 2024 Apr;11(4):ofae171

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study.

Ambrosioni J, Díaz NA, Marzolini C, Dragovic G, Imaz A, Calcagno A, Luque S, Curran A, Troya J, Tuset M, Khoo S, Burger D, Cortés CP, Naous N, Molto J

Infect Dis Ther. 2024 Mar;13(3):609-617

Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.

Favre G, Richardson JL, Moore A, Geissbühler Y, Jehl V, Oliver A, Shechtman S, Diav-Citrin O, Berlin M, De Haan T, Baud D, Panchaud A, Mor A, Sabidó M, de Souza S, Chambers C, van Rijt-Weetink YRJ, van Puijenbroek EP, Yates LM, Girardin F, Stellfeld M, Winterfeld U

Drug Saf. 2024 Mar;47(3):227-236

Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project.

van Rijt-Weetink YRJ, Egberts TCG, van Hunsel FPAM, Lewis DJ, Yates LM, Winterfeld U, van Puijenbroek EP

Drug Saf. 2024 Mar;47(3):261-270

Contrast-enhanced ultrasonography reveals a lower cortical perfusion and a decreased renal flow reserve in hypertensive patients.

Damianaki A, Hendriks-Balk M, Brito W, Polychronopoulou E, Theiler K, Maillard M, Maurer J, Eugster P, Pruijm M, Wuerzner G

Nephrol Dial Transplant. 2024 Jan 31;39(2):242-250

Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.

Berton M, Bettonte S, Stader F, Decosterd L, Tarr PE, Livio F, Cavassini M, Braun DL, Kusejko K, Hachfeld A, Bernasconi E, Calmy A, Schmid P, Battegay M, Marzolini C, Swiss HIV Cohort Study

Clin Infect Dis. 2024 Jan 25;78(1):98-110

[Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs].

Marouf R, Chtioui H, Girardin FR, Buclin T, Diezi L

Rev Med Suisse. 2024 Jan 17;20(856-7):96-101

Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.

Thoueille P, Cavassini M, Guidi M, Buclin T, Girardin FR, Decosterd LA, Marzolini C

Open Forum Infect Dis. 2024 Feb;11(2):ofae023

2023

Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.

Thoueille P, Saldanha SA, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard HF, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stöckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso RJ, Andre P, Girardin FR, Guidi M, Buclin T, Decosterd LA, Swiss HIV Cohort Study

Lancet Reg Health Eur. 2024 Jan;36:100793

The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient.

Grütter S, Haefliger D, Wuerzner G, Yerly P, Bouchardy J, Rutz T

CJC Pediatr Congenit Heart Dis. 2024 Feb;3(1):11-13

Lien IRIS - Publications du Service de pharmacologie clinique dès 2026 Lien IRIS - Publications du Service de pharmacologie clinique avant 2026

Service de pharmacologie clinique
Rue du Bugnon 17
CHUV, Centre hospitalier universitaire vaudois
CH-1011 Lausanne, Vaud, Suisse
+41 21 314 4260

Impressum
Informations juridiques
Plan du site
Formulaire de contact

Dernière mise à jour le 11/08/2026 à 13:15